mTOR inhibitors for the management of difficult lymphangioma in adults

Respir Med Res. 2020 Mar:77:8-10. doi: 10.1016/j.resmer.2019.09.001. Epub 2019 Oct 28.

¹ Hospices Civils de Lyon, Department of Respiratory Medicine, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel hospital, Lyon, France; Claude-Bernard Lyon 1 University, University of Lyon, INRA, UMR754, Lyon, France. Electronic address: vincent.cottin@chu-lyon.fr.
² Hospices Civils de Lyon, Department of Radiology, Louis-Pradel hospital, Lyon, France.
³ Hospices Civils de Lyon, Department of Respiratory Medicine, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel hospital, Lyon, France.

No abstract available

Keywords: Lymphangioma; Mediastinal tumour; Retroperitoneal tumour; Sirolimus; mTOR inhibitor.

Publication types